Kb. Hoover et al., Loss of the tight junction MAGUK ZO-1 in breast cancer - Relationship to glandular differentiation and loss of heterozygosity, AM J PATH, 153(6), 1998, pp. 1767-1773
Citations number
34
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Membrane-associated guanylate kinase homologs (MAGUKs) may play a role in c
ellular functions preventing tumorigenesis as indicated by the neoplastic p
henotype caused by genetic loss of the MAGUK Dig in Drosophila. To test thi
s possibility, we examined the expression and subcellular localization of t
he tight junction MAGUK ZO-1, as well as the cell adhesion molecule E-cadhe
rin, in paraffin-embedded breast cancer samples, using immunohistochemistry
and confocal microscopy, As expected, normal tissue showed intense stainin
g for ZO-1 at the position of the epithelial tight junctions, but this stai
ning was reduced or lost in 69% of breast cancers analyzed (II = 48). In in
filtrating ductal carcinomas (n = 38) there was a reduction in staining in
42% of well differentiated, in 83% of moderately differentiated and 93% of
poorly differentiated tumors. ZO-1 staining was positively correlated with
tumor differentiation (P =.011) and more specifically with the glandular di
fferentiation of tumors (P =.0019). Reduction in ZO-1 staining was strongly
correlated with reduced E-cadherin staining (P = 4.9 x 10(-5)). The result
s suggest that down-regulation of ZO-1 expression and its failure to accumu
late at cell junctions may be causally related to cancer progression. To de
tect loss of heterozygosity, the ZO-1 gene tjp-1 was mapped relative to oth
er markers in 15q13 and polymorphic markers flanking tjp-1 were identified.
The marker D15S1019 showed loss of heterozygosity in 23% of informative tu
mors (II = 13), Loss of a tjp-1-linked marker suggests that genetic loss ma
y, in some cases, be responsible for the reduction in ZO-1 expression in br
east cancer.